Literature DB >> 8488941

Endoscopic retrograde cholangiopancreatography after laparoscopic cholecystectomy.

L W Traverso1, R A Kozarek, T J Ball, J J Brandabur, J A Hunter, P C Jolly, D J Patterson, J A Ryan, R C Thirlby, D G Wechter.   

Abstract

We assessed the use of endoscopic retrograde cholangiopancreatography (ERCP) after laparoscopic cholecystectomy (LC) at our hepatobiliary referral center. This assessment included patients from outside institutions with post-LC problems. Between May 1990 and September 1992, we performed 522 LCs and 1,723 ERCP examinations. There were 78 patients who underwent 143 ERCP examinations after LC, 65% of whom were referred. ERCP findings were categorized as follows: normal results (8%), problems inherent to stone disease (65%), and iatrogenic injury (27%). The types of inherent problems were common bile duct (CBD) stones, pancreatitis, and papillary stenosis/microlithiasis. Within the CBD stone group, 5 of 26 patients also had papillary stenosis, and, within the pancreatitis group, 9 of 11 patients also had papillary stenosis, making papillary stenosis the most frequent observation (55%). Almost all of these patients (96%) required endoscopic papillotomy for successful treatment. The iatrogenic injury group was comprised of 21 patients, 16% of whom had cystic duct leak and 84% of whom had CBD injury. These patients required a variety of endoscopic procedures including endoscopic papillotomy (67%), CBD endoscopic stenting (76%), percutaneous drainage of biloma (29%), and percutaneous transhepatic biliary drainage (24%). Open surgical procedures after endoscopic assessment or treatment were required in only three patients in the iatrogenic group and in none in the inherent group. At this time, long-term follow-up is not possible with regard to biliary stricture. We conclude that the majority of problems after LC are either due to papillary stenosis/microlithiasis with or without CBD stones or to biliary injury. Both can be successfully diagnosed and treated with endoscopic techniques.

Entities:  

Mesh:

Year:  1993        PMID: 8488941     DOI: 10.1016/s0002-9610(05)80439-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  SSAT/SAGES minimally invasive surgeryAdvanced laparoscopic hepatobiliary surgery

Authors: 
Journal:  Surg Endosc       Date:  1998-04       Impact factor: 4.584

2.  The long-term follow-up of patients with positive intraoperative cholangiograms during laparoscopic cholecystectomy.

Authors:  A J Wagner; M A Sobrino; L W Traverso
Journal:  Surg Endosc       Date:  2004-10-13       Impact factor: 4.584

3.  Endolaparoscopic rendezvous treatment: a satisfying therapeutic choice for cholecystocholedocolithiasis.

Authors:  A Tricarico; G Cione; M Sozio; P Di Palo; V Bottino; T Tricarico; A Tartaglia; I Iazzetta; E Sessa; S Mosca; C De Nucci; P Falco
Journal:  Surg Endosc       Date:  2001-12-31       Impact factor: 4.584

4.  Handling of biliary complications following laparoscopic cholecystectomy in the setting of Tripoli Central Hospital.

Authors:  A Elhamel; S Nagmuish; S Elfaidi; H Ben Dalal
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

5.  Laparoscopic antegrade sphincterotomy. A new technique for the management of complex choledocholithiasis.

Authors:  M J Curet; D E Pitcher; D T Martin; K A Zucker
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

6.  Treatment of bile duct lesions after laparoscopic cholecystectomy.

Authors:  J J Bergman; G R van den Brink; E A Rauws; L de Wit; H Obertop; K Huibregtse; G N Tytgat; D J Gouma
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

7.  The efficacy of preoperative endoscopic retrograde cholangiopancreatography in the detection and clearance of choledocholithiasis.

Authors:  E W Taylor; U Rajgopal; J Festekjian
Journal:  JSLS       Date:  2000 Apr-Jun       Impact factor: 2.172

Review 8.  Gastric outlet obstruction secondary to post cholecystectomy biloma: case report and review of the literature.

Authors:  V Dev; D Shah; F Gaw; A T Lefor
Journal:  JSLS       Date:  1998 Apr-Jun       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.